Accountable care organizations are becoming increasingly common in the United States, but they are more likely to be formed in regions of the country with populations that have a higher socioeconomic status.
Accountable care organizations (ACOs) can greatly improve healthcare quality at a low cost if all patients have equal access to physicians who participate in such ACOs. However, a new study points out the vast disparity in physicians’ participation in ACOs across hospital referral regions. It was found that disadvantaged patients do not have good access to physicians resulting in lack of good healthcare, according to a study published in Health Affairs.
While ACOs are growing, there are still certain vulnerable groups that aren't being catered to. In fact, there are concerns that ACOs are worsening existing disparities in healthcare quality, according to Laura C. Yasaitis, PhD, and colleagues.
Study Design and Results
Through data collected during 2013, the researchers studied and compared the participation of physicians in an ACO (public or commercial) updated by SK&A. They also identified each physician’s ZIP Code Tabulation Area to study the sociodemographic characteristics of the population that the physician was likely to care for. Variables at physician-level such as sex, number of physicians in the practice, whether the practice was a multispecialty, rurality of the practice location, and medical specialty were also included.
The findings after studying 521,543 US physicians were as follows:
“We found that physicians practicing in ZIP Code Tabulation Areas with more blacks, higher poverty, more uninsured or disabled residents, or more people with less than a high school education were less likely to participate in ACOs than their counterparts practicing in areas whose populations of such vulnerable groups were smaller,” said Yasaitis, the lead researcher of the study and a postdoctoral research fellow at the Perelman School of Medicine.
Better Care for Vulnerable Groups Needed
ACOs are becoming increasingly common in the United States. Between Medicare and the commercial (or private) sector, almost 23.5 million Americans are being served by an ACO. However, the latest study points out that the ACOs are concentrated in regions with lower poverty rates creating a disparity in reach. Not all patients enjoy access to ACOs, especially the vulnerable and disadvantaged groups.
The researchers found evidence confirming that ACOs are more likely to be formed in regions of the country whose populations have higher socioeconomic status and a smaller percentage of blacks, compared to regions whose populations have lower socioeconomic status and a larger percentage of blacks.
“Greater consideration is warranted in creating policies to encourage the development of ACOs and physicians’ participation in them in areas with vulnerable populations,” the authors concluded. “Additionally, any changes in the care and health outcomes of these populations should be monitored to assess the potential effects of ACO implementation on healthcare disparities.”
New Blueprint Guides Patient-Centered Research for More Equitable Health Care
July 17th 2025The new Blueprint for Patient-Centered Value Research offers a roadmap for embedding patient voices throughout every stage of the research journey to foster more equitable, transparent, and responsive health care systems.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More